Msi2 enhances muscle dysfunction in a myotonic dystrophy type 1 mouse model
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Msi2 enhances muscle dysfunction in a myotonic dystrophy type 1 mouse model
Authors
Keywords
-
Journal
Biomedical Journal
Volume -, Issue -, Pages 100667
Publisher
Elsevier BV
Online
2023-10-04
DOI
10.1016/j.bj.2023.100667
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantitative magnetic resonance imaging assessment of muscle composition in myotonic dystrophy mice
- (2023) Ariadna Bargiela et al. Scientific Reports
- Relationship between serum indirect bilirubin levels and skeletal muscle mass in older male and female patients with type 2 diabetes
- (2022) Yukihiro Inoguchi et al. PLoS One
- The Musashi proteins direct post-transcriptional control of protein expression and alternate exon splicing in vertebrate photoreceptors
- (2022) Fatimah Matalkah et al. Communications Biology
- Population Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of State-wide Blood Screening Program
- (2021) Nicholas E Johnson et al. NEUROLOGY
- Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through miR-7 biogenesis repression
- (2021) Maria Sabater-Arcis et al. Molecular Therapy-Nucleic Acids
- Relationship between Serum Alkaline Phosphatase and Low Muscle Mass Index Among Korean Adults: A Nationwide Population-Based Study
- (2021) Jun-Hyuk Lee et al. Biomolecules
- HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy
- (2020) Moyi Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features
- (2020) Tara E Crawford Parks et al. HUMAN MOLECULAR GENETICS
- Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1‐p21/ZEB‐1 pathway
- (2020) Lei Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Musashi interaction with poly(A)-binding protein is required for activation of target mRNA translation
- (2019) Chad E. Cragle et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models
- (2019) Ariadna Bargiela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transduction Efficiency of Adeno-Associated Virus Serotypes After Local Injection in Mouse and Human Skeletal Muscle
- (2019) Laura Muraine et al. HUMAN GENE THERAPY
- miR-7 Restores Phenotypes in Myotonic Dystrophy Muscle Cells by Repressing Hyperactivated Autophagy
- (2019) Maria Sabater-Arcis et al. Molecular Therapy-Nucleic Acids
- Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1
- (2018) Christina Wei et al. FASEB JOURNAL
- Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1
- (2018) Ginny R Morriss et al. HUMAN MOLECULAR GENETICS
- CRISPR‐Mediated Expression of the Fetal Scn5a Isoform in Adult Mice Causes Conduction Defects and Arrhythmias
- (2018) Paul D. Pang et al. Journal of the American Heart Association
- Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I
- (2017) Marielle Brockhoff et al. JOURNAL OF CLINICAL INVESTIGATION
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- Muscleblind-like 3 deficit results in a spectrum of age-associated pathologies observed in myotonic dystrophy
- (2016) Jongkyu Choi et al. Scientific Reports
- Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model
- (2015) A. Bargiela et al. Disease Models & Mechanisms
- Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins
- (2015) Eric T. Wang et al. GENOME RESEARCH
- The use of a viral 2A sequence for the simultaneous over-expression of both the vgf gene and enhanced green fluorescent protein (eGFP) in vitro and in vivo
- (2015) Jo E. Lewis et al. JOURNAL OF NEUROSCIENCE METHODS
- Global insights into alternative polyadenylation regulation
- (2015) Ranjan Batra et al. RNA Biology
- Differential myofiber-type transduction preference of adeno-associated virus serotypes 6 and 9
- (2015) Muhammad Riaz et al. Skeletal Muscle
- TWEAK/Fn14, a pathway and novel therapeutic target in myotonic dystrophy
- (2014) Ramesh S. Yadava et al. HUMAN MOLECULAR GENETICS
- Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs
- (2014) Sun-Mi Park et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Myotonic Dystrophy
- (2014) Charles A. Thornton NEUROLOGIC CLINICS
- MBNL proteins and their target RNAs, interaction and splicing regulation
- (2014) Patryk Konieczny et al. NUCLEIC ACIDS RESEARCH
- Tissue-specific control of brain-enriched miR-7 biogenesis
- (2013) N. R. Choudhury et al. GENES & DEVELOPMENT
- Alternative splicing regulation by Muscleblind proteins: from development to disease
- (2011) Juan M. Fernandez-Costa et al. BIOLOGICAL REVIEWS
- Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells
- (2010) E Loro et al. CELL DEATH AND DIFFERENTIATION
- Altered signal transduction pathways and induction of autophagy in human myotonic dystrophy type 1 myoblasts
- (2010) Pascale Beffy et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2
- (2008) Valerio Pisani et al. MUSCLE & NERVE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started